San Diego, CA -- (SBWIRE) -- 08/17/2022 -- Humanigen, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.

Investors who purchased shares of Humanigen, Inc. (NASDAQ: HGEN), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Humanigen, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Short Hills, NJ based Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called ?cytokine storm'. On July 13, 2022, Humanigen, Inc. disclosed that its trial of lenzilumab did not attain statistical significance on the primary endpoint of the proportion of subjects with baseline CRP<150 mg/L and aged below 85 years, alive and without needing mechanical ventilation through day 29.

Shares of Humanigen, Inc. (NASDAQ: HGEN) declined from $3.25 per share on July 8, 2022, to as low as $0.35 per share on August 9, 2022.

Those who purchased shares of Humanigen, Inc. (NASDAQ: HGEN) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Christopher Clausen
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.